We trained models to predict histological subtypes, CNV-H subtype from the entire cohort and the endometrioid patients, CNV-L subtype, MSI-high subtype, POLE subtype, and the mutation status of 18 endometrial carcinoma-related genes. This evidence concerns the gene POLE and endometrial carcinoma.